Why is Ajanta Pharma falling/rising?

As of 28-Jul, Ajanta Pharma Ltd. is experiencing a decline in its stock price, currently at 2,753.65, reflecting a decrease of 31.35 points or 1.13%. The stock has underperformed its sector by 1.21% today and has been on a consecutive downward trend for the last two days, accumulating a total decline of 1.47%. Despite a strong performance over the past year with a return of 14.71%, the stock has faced challenges in the short term, including a recent drop in delivery volume by 33.37% against the 5-day average. The stock remains above its longer-term moving averages but is currently below its 5-day moving average, indicating some short-term weakness.
In the broader market context, Ajanta Pharma's recent performance contrasts with the benchmark Sensex, which has seen a decline of 1.59% over the past week. While the stock has shown resilience with a 9.06% increase over the past month, its year-to-date performance is down by 6.52%, suggesting some volatility. The company benefits from high management efficiency, a low debt-to-equity ratio, and strong institutional holdings, which may provide a buffer against market fluctuations. However, the recent drop in investor participation and the stock's underperformance today indicate that market sentiment may be cautious, impacting its price movement negatively.